Rabies DNA vaccines for protection and therapeutic treatment

Bibliography

• FISHBEIN DB, ROBINSON LE: Rabies. New Engl. J. Med. (1993) 329:1632–1638.
   PubMed Web of Science ®Google Scholar
• SPENCER LM: Taking a bite out of rabies. J. Am. Vet. Med. Assoc. (1994) 204:479–484.
   PubMed Web of Science ®Google Scholar
• STEELE HH: Rabies in the Americas and remarks on global aspects. Rev. Infect. Dis. (1988) 10\(Supp1.4):585–597.
   Google Scholar
• MESLIN FX, FISHBIEN DB, MATTER HC: Rationale and prospects for rabies elimination in developing coun-tries. In: Lyssaviruses. Rupprecht CE, Dietzschold B, and Koprowski H (Eds.), Springer Verlag, New York (1994):1–26.
   Google Scholar
• NOAH DL, SMITH MG, GOTTHARDT JC et al.: Mass hu-man exposure to rabies in New Hampshire: expo-sures, treatment, and cost. Am. J. Pub. Hth. (1996) 86:1149–1151.
   PubMed Web of Science ®Google Scholar
• SMITH JS, SEIDEL HD: Rabies: A new look at an old dis-ease. In: Prog. Med. Virol Melnick JL (Ed.), Karger, Basel (1993):82–106.
   Google Scholar
• KOPROWSKI H: Visit to an ancient curse. Sci. Am. Sci.Med. (1995) 2:48–57.
   Google Scholar
• PRINGLE CR: The Order Mononegavirales. Arch. Vim].(1990:137–140.
   Google Scholar
• PERRY LL, LODMELL DL: Role of CD4+ and CD8+ T cells in murine resistance to street rabies virus. J. Vim]. (1991) 65:3429–3434.
   Web of Science ®Google Scholar
• ••Protection against rabies virus is associated with virus-neutralizing antibody directed against G.
   Google Scholar
• XIANG ZQ, KNOWLES BB, MCCARRICK JW, ERTL HC: Im- mune effector mechanisms required for protection to rabies virus. Virology (1995) 214:398–404.
   PubMed Web of Science ®Google Scholar
• ••Protection against rabies virus is associated with virus-neutralizing antibody directed against G.
   Google Scholar
• SUGAMATA M, MIYAZAWA M, MORI S, SPANGRUDE J, EWALT LC, LODMELL DL: Paralysis of street rabies virus-infected mice is dependent on T lymphocytes. J. Vim]. (1992) 66:1252–1260.
   Web of Science ®Google Scholar
• FUJII H, MANNEN K, TAKITA-SONODA Y et al.: Target cells of cytotoxic T lymphocytes directed to the indi-vidual structural proteins of rabies virus. Microbiol. Im-munol (1994) 38:721–726.
   PubMed Web of Science ®Google Scholar
• LODMELL DL, ESPOSITO JJ, EWALT LC: Rabies virus anti- nucleoprotein antibody protects against rabies virus challenge in vivo and inhibits rabies virus replication in vitro. J. Vim]. (1993) 67:6080–6086.
   Web of Science ®Google Scholar
• LODMELL DL, SUMNER JW, ESPOSITO JJ, BELLINI WJ, EWALT LC: Racoon poxvirus recombinants expressing the rabies virus nucleoprotein protect mice against le-thal rabies virus infection. J. Vim]. (1991) 65:3400–3405.
   Web of Science ®Google Scholar
• SUMNER JW, FEKADU M, SHADDOCK JJ, ESPOSITO JJ, BELLINI WJ: Protection of mice with vaccinia virus re-combinants that express the rabies nucleoprotein. Vi-rology (1991) 183:703–710.
   Google Scholar
• LODMELL DL, SMITH JS, ESPOSITO JJ, EWALT LC: Cross- protection of mice against a global spectrum of rabies virus variants. J. Virol (1995) 69:4957-4962. HOENIG LJ: Triumph and controversy-Pasteur's pre-ventative treatment of rabies as reported in the JAMA. Arch. Neurol (1986) 34:397-399. Descriptive report of the initiation of the modern era of ra-bies prevention. WHO EXPERT COMMITTEE ON RABIES. World Health Or-ganization Technical Report Series, 8th report. (1992) 824:24–2512.
   Google Scholar
• VODOPIJA R, LAFONT M, BAKLAIC Z et al.: Persistence of humoral immunity to rabies 1100 days after immuni-zation and effect of a single booster dose of rabies vac-cine. Vaccine (1997) 15:571–574.
   PubMed Web of Science ®Google Scholar
• KING AA, TURNER GS: Rabies: A review. J. Comp. Path. (1993) 108:1–39.
   PubMed Web of Science ®Google Scholar
• DUTTA JK: Rabies prevention: Cost to an Indian la-borer. JAMA (1996) 276:32.
   PubMed Web of Science ®Google Scholar
• ROBINSON HL, TORRES CA: DNA vaccines. Semin. Immu-nol. (1997) 9:271–283.
   PubMedGoogle Scholar
• •A review of DNA vaccines. LAI WC, BENNETT M: DNA vaccines. Grit. Reviews. Immu-nol. (1998) 18:449-484. A review of DNA vaccines. MANICKAN E, KAREM KL, ROUSE BT: DNA vaccines- A modern gimmick or a boon to vaccinology? Grit. Re-views Immunol. (1997) 17:139-154. A review of DNA vaccines.
   Google Scholar
• TIGHE H, CORR M, ROMAN M, RAY E: Gene vaccination: plasmid DNA is more than just a blueprint. Immunol Today (1998) 19:89–97.
   PubMedGoogle Scholar
• •A review of DNA vaccines.
   Google Scholar
• KOPROWSKI H, WEINER DB (Eds.): DNA Vaccina-tion/Genetic Vaccination. In: Curr. Top. Microbiol. Im-munol. Springer, New York (1998) 226:1–198.
   PubMed Web of Science ®Google Scholar
• •A review of DNA vaccines. KUCEROVA L: DNA/genetic vaccination. Vim]. Immunol. (1998) 11:55-63. A review of DNA vaccines. XIANG ZQ, SPITALNIK S, TRAN M, WUNNER WH, ERTL HCJ: Vaccination with a plasmid vector carrying the ra-bies virus glycoprotein gene induces protective immu-nity against rabies virus. Virology (1994) 199:132-140. The initial report concerning protection against rabies virus with a DNA vaccine.
   Google Scholar
• BURGER SR, REMALEY AT, DANLY JM et al.: Stable ex- pression of rabies virus glycoprotein in Chinese ham-ster ovary cells. J. Gen. Vim]. (1991) 72:359–367.
   PubMed Web of Science ®Google Scholar
• XIANG ZQ, SPITALNIK SL, CHENG J, WOJCZYK B, ERTL HC: Immune responses to nucleic acid vaccines to ra-bies virus. Virology (1995) 209:569–579.
   PubMed Web of Science ®Google Scholar
• RAY NB, EWALT LC, LODMELL DL: Nanogram quantities of plasmid DNA encoding the rabies virus glycopro-tein protect mice against lethal rabies virus infection. Vaccine (1997) 15:892–895.
   PubMed Web of Science ®Google Scholar
• LODMELL DL, RAY NB, EWALT LC: Gene gun particle- mediated vaccination with plasmid DNA confers pro-tective immunity against rabies virus infection. Vac-cine (1998) 16:115–118.
   PubMed Web of Science ®Google Scholar
• LODMELL DL, RAY NB, PARNELL MG et al.: DNA immuni- zation protects nonhuman primates against rabies vi-rus. Nat. Med. (1998) 4:949–952.
   PubMed Web of Science ®Google Scholar
• ••The initial report concerning protection of nonhuman pri-mates against rabies virus with a DNA vaccine.
   Google Scholar
• BOHLOUL C, JACOB Y, TORDO N, PERRIN P: DNA-based immunization for exploring the enlargement of im-munological cross-reactivity against the lyssaviruses. Vaccine (1998) 16:417–425.
   PubMed Web of Science ®Google Scholar
• TOKUNAGA T, YANO 0, KUAMOTO E et al.: Synthetic oligonucleotides with particular base sequences from the cDNA encoding proteins of Mycobacterium bovis BCG induce interferons and activate natural killer cells. Microbiol. Immunol. (1992) 36:55–66.
   Google Scholar
• KLINMAN DM, YAMSHCHIKOV G, ISHIGATSUBO Y: Con- tribution of CpG motifs to the immunogenicity of DNA vaccines. J. Immunol. (1997) 158:3635–3639.
   PubMed Web of Science ®Google Scholar
• SATO Y, ROMAN M, LEE D et al: Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science (1996) 273:352–354.
   PubMed Web of Science ®Google Scholar
• ••ISS within a plasmid backbone stimulate the immunesystem.
   Google Scholar
• LIPFORD GB, SPARWASSER T, BAUER M et al: Immu-nostimulatory DNA: sequence-dependent production of potentially harmful or useful cytokines. Eur. J. Im-munol. (1997) 27:33420–33426.
   Google Scholar
• ROMAN M, MARTIN-OROZCO E, GOODMAN JS et al.: Im-munostimulatory DNA sequences function as T helper-l-promoting adjuvants. Nat. Med. (1997) 3:849–854.
   PubMed Web of Science ®Google Scholar
• LEE SW, SUNG YC: Immuno-stimulatory effects of bacterial-derived plasmids depend on the nature of the antigen in intramuscular DNA inoculations. Immu-nology (1998) 94:285–289.
   Google Scholar
• WLOCH, MK, PASQUINI S, ERTL HC, PISETSKY DS: The in-fluence of DNA sequence on the immumostimulatory properties of plasmid DNA vectors. Hum. Gene. Ther. (1998) 9:1439–1447.
   PubMedGoogle Scholar
• KISHIMOTO T, HIRANO T: Molecular regulation of B lymphocyte response. Annu. Rev. Immunol (1988) 6:485–496.
   PubMed Web of Science ®Google Scholar
• CHOW YH, HUANG WK, CHI YD et al: Improvement of hepatitis B virus DNA vaccines by plasmids coexpress-ing hepatitis B surface antigen and interleukin-2. J. Vi-rol. (1997) 71:169–178.
   PubMed Web of Science ®Google Scholar
• IWASAKI A, STIERNHOLM JN, CHAN AK et al.: Enhanced CTL responses mediated by plasmid DNA immuno-gens encoding costimulatory molecules and cytoki-nes. J. Immunol (1997) 158:4591–4601.
   PubMed Web of Science ®Google Scholar
• ••Co-expression of immune modulators enhances the im-mune response to DNA vaccines.
   Google Scholar
• XIANG Z, ERTL HCJ: Manipulation of the immune re- sponse to a plasmid-encoded viral antigen by coinocu-lation with plasmids expressing cytokines. Immunity (1995) 2:129–135.
   PubMed Web of Science ®Google Scholar
• ••Co-inoculation of plasmid DNA encoding GM-CSF enhancesthe immune response to a rabies DNA vaccine.
   Google Scholar
• CHOW YH, CHIANG BL, LEE YL et al.: Development of Till and Th2 populations and the nature of immune responses to hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine genes. J. Immunol. (1998) 160:1320–1329.
   PubMed Web of Science ®Google Scholar
• KIM JJ, BAGARAZZI ML, TRIVEDI N et al.: Engineering of in vivo immune responses to DNA immunization via codelivery of costimulatory molecule genes. Nat. Bio-tech. (1997) 15:641–646.
   PubMed Web of Science ®Google Scholar
• KIM JJ, AYYAVO0 V, BAGARAZZI ML et al.: In vivo engi-neering of a cellular immune response by coadminis-tration of IL-12 expression vector with a DNA immunogen. J. Immunol. (1997) 158:816–826.
   Google Scholar
• SASAKI S, TSUJI T, HAMAJIMA K et al.: Monophosphoryl lipid A enhances both humoral and cell-mediated im-mune responses to DNA vaccination against human immunodeficiency virus Type 1. Infect. and Immun. (1997) 65:3520–3528.
   PubMed Web of Science ®Google Scholar
• KUKLIN N, MASSOUD D, KAREM K, MANICKAN E, ROUSE BT: Induction of mucosal immunity against herpes simplex virus by plasmid DNA immunization. J. Vim]: (1997) 71:3138–3145.
   Web of Science ®Google Scholar
• CHEN SC, JONES DH, FYNAN EF et al.: Protective immu-nity induced by oral immunization with a rotavirus DNA vaccine encapsulated in microparticles. J. Vim]: (1998) 72:5757–5761.
   Web of Science ®Google Scholar
• JONES DH, CORRIS S, MCDONALD S, CLEGG JCS, FARRAR GH: Poly(DL-lactide-co-glycolide) -encapsulated plas-mid DNA elicits systemic and mucosal antibody re-sponses to encoded protein after oral administration. Vaccine (1997) 15:814–817.
   PubMed Web of Science ®Google Scholar
• GREGORIADIS G: Genetic vaccines: strategies for opti-mization. Pharm. Res. (1998) 15:661–670.
   PubMed Web of Science ®Google Scholar
• DAVIS HL, DEMENEIX BA, QUANTIN B, COULOMBE J, WHALEN RG: Plasmid DNA is superior to viral vectors for direct gene transfer into adult mouse skeletal mus-cle. Human Gene Ther. (1993) 4:733–740.
   PubMed Web of Science ®Google Scholar
• WANG B, BOYER J, SRIKANTAN V et al.: DNA inoculation induces neutralizing immune responses against hu-man immunodeficiency virus Type 1 in mice and non-human primates. DNA and Cell Biol. (1993) 12:799–805.
   PubMed Web of Science ®Google Scholar
• TIMARES L, TAKASHIMA A, JOHNSTON SA: Quantitative analysis of the immunopotency of genetically trans-fected dendritic cells. Proc. Natl. Acad. Sci. USA (1998) 95:13147–13152.
   PubMed Web of Science ®Google Scholar
• BOYLE JS, BRADY JL, LEW AM: Enhanced responses to a DNA vaccine encoding a fusion antigen that is directed to sites of immune induction. Nature (1998) 392:408–410.
   PubMed Web of Science ®Google Scholar
• ••A DNA vaccine encoding a fusion antigen accelerates andenhances cellular and humoral immune responses.
   Google Scholar
• ARBONES ML, ORD DC, LEY K et al: Lymphocyte hom-ing and leukocyte rolling and migration are impaired in L-selectin-deficient mice. Immunity (1994) 1:247–260.
   PubMed Web of Science ®Google Scholar
• CATALINA MD, CARROLL MC, ARIZPE H, TAKASHIMA A, ESTESS P, SIEGELMAN MH: The route of antigen entry determines the requirement for L-selectin during im-mune responses. J. Exp. Med. (1996) 184:2341–2351.
   PubMed Web of Science ®Google Scholar
• LINSLEY PS, CLARK EA, LEDBETTER JA: T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1. Proc. Natl. Acad. Sci. USA (1990) 87:5031–5035.
   PubMed Web of Science ®Google Scholar
• FORG P, VON HOEGEN P, DALEMANS W, SCHIRRMA-CHER V: Superiority of the ear pinna over muscle tissue as site for DNA vaccination. Gene Ther. (1998) 5:789–797.
   PubMed Web of Science ®Google Scholar
• BABIUK LA, LEWIS PJ, VAN DRUNEN LITTLE-VAN DEN HURK S, TIKOO S, LIANG X: Nucleic acid vaccines: vet-erinary applications. Curr. Top. Microbiol. Immunol. (1998) 226:90-106. Donald L Lodmell Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, Hamilton, MT 59840, USA(Tel.:+1 406 363 9360: Fax:+1 406 363 9286 Email: [email protected])
   Google Scholar